Large Outflow of Money Witnessed in Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc (TMO) : The money flow is calculated as the dollar value of composite uptick trades minus the dollar value of downtick trades, which was negative (14.51 million) in Thermo Fisher Scientific Inc (TMO). On Friday, The value of composite uptick trades was $19.71 million, whereas, the value of composite downtick trades was $34.22 million and the ratio between the two was 0.58, indicating selling on strength. Traders involved in block trades booked profits in their holdings as seen in the transactions on downticks valued at $10.53 million. The negative money flow of ($10.53 million) shows selling on strength. Thermo Fisher Scientific Inc (TMO) gained $0.67 intraday at $156.87 and registrered 0.43% for the week.


Thermo Fisher Scientific Inc (TMO) : The highest short term price target forecast on Thermo Fisher Scientific Inc (TMO) is $175 and the lowest target price is $105. A total of 11 equity analysts are currently covering the company. The average price of all the analysts is $160.18 with a standard deviation of $19.31.

Thermo Fisher Scientific Inc (NYSE:TMO): stock turned positive on Friday. Though the stock opened at $156.82, the bulls momentum made the stock top out at $157.37 level for the day. The stock recorded a low of $156.02 and closed the trading day at $156.89, in the green by 0.44%. The total traded volume for the day was 901,937. The stock had closed at $156.2 in the previous days trading.

In a related news, Loewald Thomas W, officer (Senior Vice President) of Thermo Fisher Scientific Inc., unloaded 8,025 shares at an average price of $155 on July 13, 2016. The total amount of the transaction was worth $1,243,875, according to the disclosed information with the Securities and Exchange Commission in a Form 4 filing.

Thermo Fisher Scientific Inc. is a provider of analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. The company operates through four segments: Life Sciences Solutions, provides reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines as well as diagnosis of disease; Analytical Instruments, provides instruments, consumables, software and services that are used in the laboratory; Specialty Diagnostics, offers diagnostic test kits, reagents, culture media, instruments and associated products, and Laboratory Products and Services, offers self-manufactured and sourced products for the laboratory.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.